NeuroMetrix, Inc. (NURO)
USD 4.47
(1.08%)
USD 4.47
(1.08%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.9 Million USD | -28.52% |
| 2022 | 8.25 Million USD | 0.03% |
| 2021 | 8.25 Million USD | 11.87% |
| 2020 | 7.37 Million USD | -20.43% |
| 2019 | 9.27 Million USD | -42.37% |
| 2018 | 16.09 Million USD | -5.86% |
| 2017 | 17.09 Million USD | 42.11% |
| 2016 | 12.02 Million USD | 64.76% |
| 2015 | 7.29 Million USD | 32.42% |
| 2014 | 5.51 Million USD | 4.43% |
| 2013 | 5.27 Million USD | -30.32% |
| 2012 | 7.57 Million USD | -27.14% |
| 2011 | 10.39 Million USD | -25.2% |
| 2010 | 13.89 Million USD | -46.82% |
| 2009 | 26.13 Million USD | -16.01% |
| 2008 | 31.12 Million USD | -30.26% |
| 2007 | 44.62 Million USD | -19.24% |
| 2006 | 55.24 Million USD | 61.09% |
| 2005 | 34.29 Million USD | 91.39% |
| 2004 | 17.92 Million USD | 95.47% |
| 2003 | 9.16 Million USD | 116.98% |
| 2002 | 4.22 Million USD | 21.96% |
| 2001 | 3.46 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 769.14 Thousand USD | -29.67% |
| 2024 Q3 | 587.31 Thousand USD | -23.64% |
| 2024 Q1 | 1.09 Million USD | -17.01% |
| 2023 Q1 | 1.72 Million USD | -6.64% |
| 2023 Q2 | 1.65 Million USD | -4.0% |
| 2023 Q3 | 1.2 Million USD | -27.33% |
| 2023 FY | 5.9 Million USD | -28.52% |
| 2023 Q4 | 1.31 Million USD | 9.52% |
| 2022 Q4 | 1.84 Million USD | -6.13% |
| 2022 FY | 8.25 Million USD | 0.03% |
| 2022 Q1 | 2.3 Million USD | 26.49% |
| 2022 Q2 | 2.13 Million USD | -7.13% |
| 2022 Q3 | 1.96 Million USD | -7.96% |
| 2021 Q3 | 2.06 Million USD | -6.74% |
| 2021 Q4 | 1.82 Million USD | -11.83% |
| 2021 Q1 | 2.15 Million USD | 19.1% |
| 2021 Q2 | 2.21 Million USD | 2.69% |
| 2021 FY | 8.25 Million USD | 11.87% |
| 2020 Q3 | 2.03 Million USD | 49.72% |
| 2020 Q4 | 1.8 Million USD | -11.12% |
| 2020 FY | 7.37 Million USD | -20.43% |
| 2020 Q2 | 1.35 Million USD | -37.39% |
| 2020 Q1 | 2.17 Million USD | 27.25% |
| 2019 Q2 | 2.35 Million USD | -24.6% |
| 2019 Q3 | 2.08 Million USD | -11.33% |
| 2019 Q4 | 1.7 Million USD | -18.25% |
| 2019 FY | 9.27 Million USD | -42.37% |
| 2019 Q1 | 3.12 Million USD | -16.25% |
| 2018 FY | 16.09 Million USD | -5.86% |
| 2018 Q4 | 3.72 Million USD | 1.69% |
| 2018 Q3 | 3.66 Million USD | -2.26% |
| 2018 Q2 | 3.75 Million USD | -24.1% |
| 2018 Q1 | 4.94 Million USD | 0.27% |
| 2017 Q3 | 3.54 Million USD | -17.71% |
| 2017 Q2 | 4.31 Million USD | 0.09% |
| 2017 Q1 | 4.3 Million USD | 15.9% |
| 2017 FY | 17.09 Million USD | 42.11% |
| 2017 Q4 | 4.92 Million USD | 38.99% |
| 2016 FY | 12.02 Million USD | 64.76% |
| 2016 Q2 | 2.64 Million USD | 16.36% |
| 2016 Q3 | 3.38 Million USD | 28.03% |
| 2016 Q4 | 3.71 Million USD | 9.62% |
| 2016 Q1 | 2.27 Million USD | -16.88% |
| 2015 Q2 | 1.22 Million USD | -4.52% |
| 2015 Q1 | 1.28 Million USD | -8.99% |
| 2015 Q4 | 2.73 Million USD | 33.25% |
| 2015 FY | 7.29 Million USD | 32.42% |
| 2015 Q3 | 2.05 Million USD | 67.71% |
| 2014 Q3 | 1.42 Million USD | 6.26% |
| 2014 Q4 | 1.4 Million USD | -1.27% |
| 2014 FY | 5.51 Million USD | 4.43% |
| 2014 Q1 | 1.33 Million USD | -5.04% |
| 2014 Q2 | 1.34 Million USD | 0.92% |
| 2013 Q2 | 1.16 Million USD | -17.2% |
| 2013 Q1 | 1.4 Million USD | -7.99% |
| 2013 Q4 | 1.4 Million USD | 6.65% |
| 2013 FY | 5.27 Million USD | -30.32% |
| 2013 Q3 | 1.31 Million USD | 13.29% |
| 2012 Q4 | 1.52 Million USD | -13.69% |
| 2012 Q1 | 2.08 Million USD | -11.79% |
| 2012 FY | 7.57 Million USD | -27.14% |
| 2012 Q2 | 2.2 Million USD | 5.97% |
| 2012 Q3 | 1.76 Million USD | -20.0% |
| 2011 FY | 10.39 Million USD | -25.2% |
| 2011 Q1 | 2.9 Million USD | -5.27% |
| 2011 Q3 | 2.56 Million USD | -0.45% |
| 2011 Q4 | 2.35 Million USD | -7.83% |
| 2011 Q2 | 2.57 Million USD | -11.46% |
| 2010 FY | 13.89 Million USD | -46.82% |
| 2010 Q4 | 3.06 Million USD | -10.19% |
| 2010 Q3 | 3.41 Million USD | -11.37% |
| 2010 Q2 | 3.85 Million USD | 3.76% |
| 2010 Q1 | 3.71 Million USD | -40.36% |
| 2009 Q3 | 6.32 Million USD | -6.43% |
| 2009 FY | 26.13 Million USD | -16.01% |
| 2009 Q4 | 6.22 Million USD | -1.59% |
| 2009 Q1 | 6.82 Million USD | 9.22% |
| 2009 Q2 | 6.76 Million USD | -0.95% |
| 2008 Q2 | 8.49 Million USD | -6.65% |
| 2008 Q1 | 9.09 Million USD | -9.91% |
| 2008 FY | 31.12 Million USD | -30.26% |
| 2008 Q3 | 7.28 Million USD | -14.28% |
| 2008 Q4 | 6.24 Million USD | -14.17% |
| 2007 Q3 | 11.29 Million USD | -1.62% |
| 2007 Q2 | 11.47 Million USD | -2.4% |
| 2007 Q4 | 10.09 Million USD | -10.55% |
| 2007 FY | 44.62 Million USD | -19.24% |
| 2007 Q1 | 11.75 Million USD | -17.17% |
| 2006 FY | 55.24 Million USD | 61.09% |
| 2006 Q1 | 11.82 Million USD | 14.44% |
| 2006 Q2 | 13.97 Million USD | 18.16% |
| 2006 Q4 | 14.19 Million USD | -6.99% |
| 2006 Q3 | 15.26 Million USD | 9.24% |
| 2005 Q2 | 8.06 Million USD | 18.82% |
| 2005 FY | 34.29 Million USD | 91.39% |
| 2005 Q4 | 10.33 Million USD | 13.41% |
| 2005 Q3 | 9.1 Million USD | 12.92% |
| 2005 Q1 | 6.78 Million USD | 17.58% |
| 2004 FY | 17.92 Million USD | 95.47% |
| 2004 Q4 | 5.77 Million USD | 19.82% |
| 2004 Q1 | 3.03 Million USD | 5.57% |
| 2004 Q2 | 4.29 Million USD | 41.77% |
| 2004 Q3 | 4.81 Million USD | 12.18% |
| 2003 Q2 | 2.08 Million USD | 28.9% |
| 2003 FY | 9.16 Million USD | 116.98% |
| 2003 Q4 | 2.87 Million USD | 10.97% |
| 2003 Q1 | 1.62 Million USD | 0.0% |
| 2003 Q3 | 2.58 Million USD | 23.79% |
| 2002 FY | 4.22 Million USD | 21.96% |
| 2001 FY | 3.46 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 51.062% |
| BrainsWay Ltd. | 31.78 Million USD | 81.433% |
| Cerus Corporation | 156.36 Million USD | 96.226% |
| Envoy Medical, Inc. | 316 Thousand USD | -1767.54% |
| electroCore, Inc. | 16.03 Million USD | 63.185% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -816.37% |
| IceCure Medical Ltd | 3.22 Million USD | -82.763% |
| Inogen, Inc. | 315.66 Million USD | 98.13% |
| OrthoPediatrics Corp. | 148.73 Million USD | 96.032% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -143.057% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -1516.833% |
| MaxCyte, Inc. | 41.28 Million USD | 85.707% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -202.259% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -5228.697% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.21% |
| PAVmed Inc | 2.45 Million USD | -140.678% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 73.794% |
| RxSight, Inc. | 89.07 Million USD | 93.375% |
| Sight Sciences, Inc. | 81.05 Million USD | 92.719% |
| SI-BONE, Inc. | 138.88 Million USD | 95.751% |
| TELA Bio, Inc. | 58.45 Million USD | 89.904% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 96.846% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 57.239% |
| Acutus Medical, Inc. | 7.16 Million USD | 17.624% |
| Talis Biomedical Corporation | 412 Thousand USD | -1332.385% |
| Spectral AI, Inc. | 18.05 Million USD | 67.316% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 40.42% |
| CVRx, Inc. | 39.29 Million USD | 84.982% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -509.207% |
| Bioventus Inc. | 512.34 Million USD | 98.848% |
| Venus Concept Inc. | 76.35 Million USD | 92.271% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 68.119% |
| LivaNova PLC | 1.15 Billion USD | 99.488% |
| 908 Devices Inc. | 50.22 Million USD | 88.251% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 98.776% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -7559.811% |
| NeuroPace, Inc. | 65.42 Million USD | 90.979% |
| LENSAR, Inc. | 42.16 Million USD | 86.004% |
| Apyx Medical Corporation | 52.34 Million USD | 88.727% |
| Cutera, Inc. | 212.36 Million USD | 97.221% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 82.309% |
| BioSig Technologies, Inc. | 18 Thousand USD | -32685.694% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 96.459% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 75.365% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.617% |
| Axonics, Inc. | 366.37 Million USD | 98.389% |
| Outset Medical, Inc. | 130.37 Million USD | 95.474% |
| IRIDEX Corporation | 51.86 Million USD | 88.622% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 95.667% |
| IRadimed Corporation | 65.56 Million USD | 90.999% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -401.822% |
| INVO Bioscience, Inc. | 3.02 Million USD | -95.374% |
| Telesis Bio, Inc. | 27.5 Million USD | 78.547% |
| Viemed Healthcare, Inc. | 183 Million USD | 96.775% |
| Varex Imaging Corporation | 811 Million USD | 99.272% |
| Quipt Home Medical Corp. | 221.74 Million USD | 97.339% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 91.407% |
| Dynatronics Corporation | 32.53 Million USD | 81.861% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 31.996% |
| Semler Scientific, Inc. | 68.18 Million USD | 91.345% |
| InMode Ltd. | 492.04 Million USD | 98.801% |
| Bruker Corporation | 2.96 Billion USD | 99.801% |
| Cytosorbents Corporation | 36.34 Million USD | 83.765% |
| DexCom, Inc. | 3.62 Billion USD | 99.837% |
| Align Technology, Inc. | 3.86 Billion USD | 99.847% |
| Viveve Medical, Inc. | 6.42 Million USD | 8.163% |
| ZimVie Inc. | 457.43 Million USD | 98.71% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 96.943% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -5228.697% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.211% |
| Profound Medical Corp. | 7.33 Million USD | 19.501% |
| Insulet Corporation | 1.69 Billion USD | 99.652% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 95.319% |
| iCAD, Inc. | 17.31 Million USD | 65.923% |
| Nuwellis, Inc. | 8.86 Million USD | 33.423% |
| Biotricity, Inc. | 12.06 Million USD | 51.08% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 98.802% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | 4.892% |
| PAVmed Inc. | 2.45 Million USD | -140.678% |
| BIOLASE, Inc. | 49.16 Million USD | 87.996% |
| Beyond Air, Inc. | 1.15 Million USD | -409.182% |
| FONAR Corporation | 102.88 Million USD | 94.264% |
| AxoGen, Inc. | 159.01 Million USD | 96.289% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 97.85% |
| Inari Medical, Inc. | 493.63 Million USD | 98.804% |
| UFP Technologies, Inc. | 400.07 Million USD | 98.525% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -31628.091% |
| Tenon Medical, Inc. | 2.92 Million USD | -101.551% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 13.368% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.816% |
| Sintx Technologies, Inc. | 2.62 Million USD | -124.645% |
| NanoVibronix, Inc. | 2.28 Million USD | -158.494% |
| Quanterix Corporation | 122.36 Million USD | 95.177% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 75.819% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 97.057% |
| TransMedics Group, Inc. | 241.62 Million USD | 97.558% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 57.403% |
| Hyperfine, Inc. | 11.03 Million USD | 46.506% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 96.427% |
| Biomerica, Inc. | 5.41 Million USD | -8.983% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 88.328% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 96.668% |